Tag: FUJIFILM

Fujifilm Holdings Corporation, better known as Fujifilm or simply Fuji, stylized as FUJiFILM, is a Japanese multinational photography and imaging company headquartered in Tokyo.

FUJIFILM Corporation is Providing Correct Information Regarding Avigan Tablet

Avigan Tablet was approved for manufacture and sale in Japan in 2014 as an influenza antiviral drug. The drug is to be considered for use only when there is an outbreak of novel or re-emerging influen...

Fujifilm Invests $83M to Expand Biotechnologies Microbial

FUJIFILM Corporation announced that it will invest approximately 9 billion yen ($83M USD) to expand the microbial production capacity of FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP C...

FUJIFILM Diosynth Biotechnologies Breaks Ground On A New BioCampus At Its Billingham

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development ...

FUJIFILM Start Capacity Expansion of “Flexible Biomanufacturing Facility”

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the devel...

Fujifilm Diosynth Biotechnologies Expansion to Add Cell and Microbial Capacity

FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a Biologics Contract Development and Manufacturing Organization with experience focused on the development and manufacture of recombinant biopharm...

FUJIFILM Diosynth Announced Gene Therapy Services Expansion

gene
FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has announced the expansion of its gene therapy services with the additio...

FUJIFILM in Exclusive Licensing Agreement with Cynata

FUJIFILM Corporation announced that it has signed an exclusive licensing agreement with Cynata Therapeutics Limited (Chief Executive Officer: Ross Macdonald), an Australian bio-venture, to obtain worl...

FUJIFILM Irvine Scientific Opens Facility in Netherlands

FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open a third manufacturing facility located in Tilburg, Neth...

Fujifilm to Acquire Biogen Manufacturing Site

FUJIFILM Corporation (“Fujifilm”) today announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød ne...

Fujifilm Partners with Universities to Grow Bioprocessing

Leading contract development and manufacturing organisation (CDMO) Fujifilm Diosynth Biotechnologies has announced a strategic partnership with a number of academic institutions to expand its bioproce...

Fujifilm Presents Advanced Mammalian Expression System

FUJIFILM Diosynth Biotechnologies (Fujifilm), a CDMO with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies, has introduced its next generation Apollo ...

Fujifilm Invests $90m to Expand its FDB

Fujifilm Corporation announced plans to invest approximately $90 million to expand its bio contract development and manufacturing organization (CDMO) business— Fujifilm Diosynth Biotechnologies (FDB)....

Voyager Therapeutics entered into collaboration with Brammer Bio and Fujifilm

microgen
Voyager Therapeutics announced that it has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand manufacturing capabilities.

FUJIFILM Diosynth Biotechnologies receives investment for its bioscience campus

bioprocessing
A £7 million (approximately €7,9 million) investment into FUJIFILM Diosynth Biotechnologies facility has been agreed by the local authorities of Tees Valley (UK).

Fujifilm developed new technology to advance the process of drug development

fujifilm
FUJIFILM has developed AI and simulation technology capable of automatically searching and designing new drug candidates from the structural formula of a known biologically active compound.

Fujifilm will start testing of the new stem cell therapy

stem-cell
Fujifilm will apply for permission as soon as this fiscal year to run clinical trials on a treatment using a type of stem cell derived from adult tissue.